| 摘要 |
FIELD: medicine.SUBSTANCE: invention refers to biotechnology, more specifically to a response test to the hospital infection in a patient suffering from a septic shock, and can be used in medicine. A biological sample specified in the patient's blood, serum, saliva, tissue or circulating cells is prepared, and a biological material: nucleic acid or protein is extracted from the biological sample. A reagent specific to the S100A9 target gene expression product specified in an amplification primer, a hybridisation probe and/or antibody is used to determine the S100A9 target gene expression.EFFECT: invention enables stating the response to the hospital infection in the patient suffering from the septic shock as shown by the S100A9 target gene overexpression to a certain threshold.11 cl, 2 dwg, 3 tbl, 5 ex |
